PFIZER INC — Director's Dealing 2023

Aug 4, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2023-07-27

Reporting Person: BOSHOFF CHRISTOFFEL (Executive Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	101554.0000	Direct
Common Stock	605.0000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Appreciation Rights	$27.3400	2024-02-23	Common Stock (9752.0000)		Direct
Stock Appreciation Rights	$30.1700	2025-02-22	Common Stock (8741.0000)		Direct
Stock Appreciation Rights	$31.3100	2027-02-27	Common Stock (21127.0000)		Direct
Stock Appreciation Rights	$33.8200	2028-02-25	Common Stock (16688.0000)		Direct
Stock Appreciation Rights	$38.7100	2026-02-28	Common Stock (12009.0000)		Direct
Stock Appreciation Rights	$42.3000	2030-02-23	Common Stock (17984.0000)		Direct
Stock Appreciation Rights	$45.9600	2029-02-24	Common Stock (10222.0000)		Direct

Footnotes

F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.